Your browser doesn't support javascript.
loading
Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation).
Chong, Pearlie P; Teiber, Dagny; Prokesch, Bonnie C; Arasaratnam, Reuben J; Peltz, Matthias; Drazner, Mark H; Garg, Sonia.
Afiliação
  • Chong PP; Division of Infectious Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Teiber D; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Prokesch BC; Division of Infectious Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Arasaratnam RJ; Division of Infectious Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Peltz M; Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Drazner MH; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Garg S; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
Transpl Infect Dis ; 20(5): e12965, 2018 Oct.
Article em En | MEDLINE | ID: mdl-29989279

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Quinazolinas / Transplante de Coração / Infecções por Citomegalovirus / Citomegalovirus / Farmacorresistência Viral / Acetatos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Quinazolinas / Transplante de Coração / Infecções por Citomegalovirus / Citomegalovirus / Farmacorresistência Viral / Acetatos Idioma: En Ano de publicação: 2018 Tipo de documento: Article